Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 8, Number 8—August 2002

Research

Pandrug-Resistant Acinetobacter baumannii Causing Nosocomial Infections in a University Hospital, Taiwan

Po-Ren Hsueh*, Lee-Jene Teng*, Cheng-Yi Chen*, Wen-Hwei Chen*, Shen-Wu Ho*Comments to Author , and Kwen-Tay Luh*
Author affiliations: *National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan;

Main Article

Table 2

Results of time-kill study of two isolates of pandrug-resistant Acinetobacter baumannii (PDRAB)

MIC (µg/mL)a
Isolate I
Isolate II
Antibiotic (clone 5) (clone 6)
Alone
Imipenem 32 32
Amikacin 128 64
Ciprofloxacin 128 2
Ampicillin-sulbactam 128 32
Combination
Imipenem + amikacin 16/64 2/4
Imipenem + ciprofloxacin 32/128 4/0.25
Imipenem + ampicillin-sulbactam 16/64 8/8
Ciprofloxacin + ampicillin-sulbactam 128/128 1/16

aValues are the lowest concentrations (µg/mL) of each agent in combination that yielded synergy.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO